Hill LaBarron K, Hu Dixie D, Koenig Julian, Sollers John J, Kapuku Gaston, Wang Xiaoling, Snieder Harold, Thayer Julian F
From the Center for the Study of Aging and Human Development (L.K.H.) and Department of Psychiatry (L.K.H.), Duke University Medical Center, Durham, North Carolina; Department of Psychology (D.D.H., J.K., J.F.T.), The Ohio State University, Columbus, Ohio; Department of Psychological Medicine (J.J.S.), The University of Auckland, Auckland, New Zealand; Georgia Prevention Institute (G.K., X.W., H.S.), Georgia Health Sciences University, Augusta, Georgia; Unit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology (H.S.), University of Groningen-University Medical Center, Groningen, the Netherlands.
Psychosom Med. 2015 Jan;77(1):16-25. doi: 10.1097/PSY.0000000000000133.
Ethnic disparities in cardiovascular morbidity and mortality are widely documented in the literature. Recently, research has shown that decreased parasympathetic cardiac modulation is associated with the established and emerging risk factors for cardiovascular disease (CVD) and stroke. In consideration of the disproportionate CVD risk and disease profile of African Americans (AAs), it is plausible that decreased cardiac parasympathetic functioning may partially explain these disparities. In the present systematic review and meta-analysis, we assess the available evidence for a reliable ethnic difference in tonic vagally mediated heart rate variability (HRV), an indicator of parasympathetic cardiac modulation.
A systematic literature search was conducted yielding studies comparing tonic HRV in AAs and European Americans. Adjusted standardized effect sizes (Hedges g) were calculated using a mixed-effects model, with restricted maximum likelihood estimation for 17 studies containing appropriate measures of vagally mediated HRV.
Meta-analysis results suggest that AAs have greater HRV than do European Americans (Hedges g = 0.93, 95% confidence interval = 0.25-1.62), even after consideration of several covariates including health status, medication use, and subgroup stratification by sex and age.
These findings suggest that decreased vagally mediated HRV is not likely to account for the persistent health disparities experienced by AAs with respect to CVD risk and burden. These disparities underscore the need for continued research addressing socioethnic cardiovascular differences and the biobehavioral mechanisms involved.
心血管疾病发病率和死亡率方面的种族差异在文献中已有广泛记载。最近,研究表明,副交感神经对心脏的调节作用减弱与心血管疾病(CVD)和中风的既定及新出现的危险因素相关。鉴于非裔美国人(AA)在心血管疾病风险和疾病特征方面存在不成比例的情况,心脏副交感神经功能下降可能部分解释了这些差异,这似乎是合理的。在本系统评价和荟萃分析中,我们评估了关于静息迷走神经介导的心率变异性(HRV)(副交感神经对心脏调节的一个指标)存在可靠种族差异的现有证据。
进行了一项系统的文献检索,得出了比较非裔美国人和欧裔美国人静息HRV的研究。使用混合效应模型计算调整后的标准化效应量(Hedges g),对17项包含迷走神经介导的HRV适当测量值的研究采用限制最大似然估计。
荟萃分析结果表明,即使考虑了包括健康状况、药物使用以及按性别和年龄进行亚组分层等几个协变量后,非裔美国人的HRV仍高于欧裔美国人(Hedges g = 0.93,95%置信区间 = 0.25 - 1.62)。
这些发现表明,迷走神经介导的HRV降低不太可能解释非裔美国人在心血管疾病风险和负担方面持续存在的健康差异。这些差异凸显了继续开展研究以解决社会种族心血管差异及相关生物行为机制的必要性。